This may be due to the increased methylation of Adrb2 (Adrenoceptor beta 2) mRNA caused by the deletion of FTO, which leads to a decrease in its mRNA and protein levels and is involved in the development of depression via the Adrb2-c-MYC-sirt1 pathway. This evidence concerns the gene FTO and major depressive disorder.